{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Description in input context": "R1441C"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "I",
            "alt": "T",
            "position": "2020"
          },
          "Description in input context": "I2020T"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005149"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro phosphorylation of Akt1 by LRRK2",
      "Material used": {
        "Material Source": "Recombinant proteins",
        "Material Name": "Recombinant human Akt1 (Histagged protein), recombinant human LRRK2 (GST - tagged protein), bovine myelin basic protein (MBP)",
        "Description": "One hundred nanograms of recombinant human Akt1 (Histagged protein) was incubated with 50 ng of recombinant human LRRK2 [glutathione - S transferase (GST)-tagged protein consisting of amino acid residues 970 - 2527; either wildtype, R1441C mutant, G2019 mutant, or I2020T mutant] in 25 μl of reaction mixture. In some experiment, bovine myelin basic protein (MBP) was used as the substrate of LRRK2."
      },
      "Readout type": "Quantitative (autoradiography for 32P - labeled proteins, Western analysis without radiolabeled c - ATP)",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "Abnormal (for mutants R1441C, G2019S, I2020T in terms of Akt1 phosphorylation compared to wild - type)",
          "Molecular Effect": "reduced interaction with, and phosphorylation of, Akt1 for mutants R1441C, G2019S, I2020T",
          "Result Description": "The three LRRK2 mutants (R1441C, G2019S, I2020T) exhibited significantly weaker kinase activity of Akt1 (Ser473)-phosphorylation than the wild - type LRRK2. When MBP was used as substrate, G2019S as well as I2020T mutant LRRK2 exhibited much stronger kinase activity than the wild - type LRRK2."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One - way ANOVA was used for statistical comparisons in some related experiments (as shown in figures for comparisons of phosphorylation levels)"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "In vitro GST pull - down assay",
      "Material used": {
        "Material Source": "Recombinant proteins",
        "Material Name": "Recombinant GST - LRRK2, GST alone, recombinant His - Akt1, glutathione agarose beads",
        "Description": "Recombinant GST - LRRK2 or GST alone was mixed with the recombinant His - Akt1 and incubated with glutathione agarose beads overnight at 4 °C in 100 μl of TNE buffer."
      },
      "Readout type": "Qualitative (Western analysis of bound proteins)",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "Abnormal (for mutants R1441C, G2019S, I2020T in terms of Akt1 binding compared to wild - type)",
          "Molecular Effect": "impaired ability to bind Akt1, particularly in the case of G2019S LRRK2 for mutants R1441C, G2019S, I2020T",
          "Result Description": "The pull - down assay using the three LRRK2 mutants (R1441C, G2019S, I2020T) showed that the reduced kinase activity toward Akt1 (Ser473) was ascribable to impaired ability to bind Akt1, particularly in the case of G2019S LRRK2."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Western analysis",
      "Material used": {
        "Material Source": "Proteins after in vitro phosphorylation and cell lysates",
        "Material Name": "Proteins from in vitro phosphorylation reactions, cell lysates from SH - SY5Y cells",
        "Description": "Proteins after in vitro phosphorylation and those in cell lysates were subjected to SDS - PAGE using a 5 - 20% gradient of e - PAGEL, blotted onto polyvinylidene fluoride membrane, and analyzed using various antibodies."
      },
      "Readout type": "Qualitative and Quantitative (protein levels and phosphorylation levels)",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "Abnormal (for LRRK2 - knockdown cells in terms of Akt1 phosphorylation compared to control)",
          "Molecular Effect": "diminished phosphorylation of Akt1 (Ser473) in LRRK2 - knockdown cells",
          "Result Description": "Transfection of LRRK2 - specific RNAi into SH - SY5Y cells reduced the level of LRRK2 protein and resulted in a marked reduction of phospho - Akt1 (Ser473), while the total level of Akt1 protein was not affected. The SH - SY5Y clone overexpressing full - length LRRK2 exhibited higher Akt1 (Ser473) phosphorylation, and knockdown of overexpressed LRRK2 reduced the phosphorylation level of Akt1."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "For experiments with SH - SY5Y cells, n = 3 biological replicates were used for statistical analysis in some cases (as shown in figures)"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One - way ANOVA was used for statistical comparisons in some related experiments (as shown in figures for comparisons of protein and phosphorylation levels)"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Knockdown of LRRK2",
      "Material used": {
        "Material Source": "Neuroblastoma SH - SY5Y cells",
        "Material Name": "SH - SY5Y cells, Stealth RNAi, V5 - tagged wild - type full - length LRRK2, neomycin gene - expressing SH - SY5Y clone",
        "Description": "For knockdown of endogenous LRRK2 expressed by neuroblastoma SH - SY5Y, cells were transfected with 25 mer of Stealth RNAi. A SH - SH5Y clone stably and uniformly overexpressing the V5 - tagged wild - type full - length LRRK2 and a SH - SY5Y clone expressing only the neomycin gene (vector control) were used."
      },
      "Readout type": "Quantitative (protein levels and phosphorylation levels by Western analysis)",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "Abnormal (for LRRK2 - knockdown cells in terms of Akt1 phosphorylation compared to control)",
          "Molecular Effect": "diminished phosphorylation of Akt1 (Ser473) in LRRK2 - knockdown cells",
          "Result Description": "Transfection of LRRK2 - specific RNAi into the cells reduced the level of LRRK2 protein and led to a marked reduction of phospho - Akt1 (Ser473), while the total level of Akt1 protein was not affected. The phosphorylation level of Akt1 [phospho - Akt1 (Ser473)/total Akt1] in the cells with LRRK2 - knockdown was reduced compared to that in the RNAi control cells."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "For experiments with SH - SY5Y cells, n = 3 biological replicates were used for statistical analysis in some cases (as shown in figures)"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "A SH - SY5Y clone expressing only the neomycin gene was used as a vector control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One - way ANOVA was used for statistical comparisons in some related experiments (as shown in figures for comparisons of protein and phosphorylation levels)"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}